Table 4.

Drug suspension for cancer patients; it must be agreed upon with the oncologist and performed according to the table.

Drug holiday in cancer patients
Active pharmaceutical ingredient	Last administration	Resume treatment
Bisphosphonate (AR)	At least 1 week before	4–6 weeks after
Denosumab (AR)	At least 1 week before	4–6 weeks after
Bevacizumab (AA)	At least 6-7 weeks before	4–6 weeks after
Sunitinib (AA)	At least 1 week before	4–6 weeks after
Everolimus (AA)	At least 1 week before	4–6 weeks after